Page 5 - Amarin News Today

The Salisbury Zoo is welcoming in its second cotton-top tamarin.

StockNews.com started coverage on shares of Amarin (NASDAQ:AMRN – Free Report) in a research note published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Several other brokerages have also recently weighed in on AMRN. Northland Securities decreased their target price on Amarin from $2.00 to $1.25 in a research […]

The Mzansi National Philharmonic Orchestra has announced that Marin Alsop will no longer be joining them for their upcoming national tour due to health reasons prohibiting her from travelling.

Amarin Co. plc (NASDAQ:AMRN – Free Report) – Research analysts at Northland Capmk cut their Q2 2023 earnings per share (EPS) estimates for Amarin in a report released on Wednesday, July 19th. Northland Capmk analyst C. Byrnes now expects that the biopharmaceutical company will post earnings of ($0.06) per share for the quarter, down from […]

LCM Capital Management Inc lifted its position in Amarin Co. plc (NASDAQ:AMRN – Free Report) by 17.8% during the 1st quarter, HoldingsChannel reports. The firm owned 331,159 shares of the biopharmaceutical company’s stock after acquiring an additional 50,000 shares during the quarter. LCM Capital Management Inc’s holdings in Amarin were worth $497,000 at the end […]

The restructuring of cardiovascular drugmaker Amarin means the layoff of about 30% of staff. Sales of Vascepa, the company’s only commercialized product, have suffered as generic versions gain traction in the market.

Amarin (NASDAQ:AMRN – Get Rating) and Sanofi (OTCMKTS:SNYNF – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, valuation, profitability, analyst recommendations, dividends, earnings and institutional ownership. Earnings & Valuation This table compares Amarin and Sanofi’s top-line revenue, earnings […]

-- VASCEPA Approved by the National Medical Products Administration (NMPA) as an Adjunct to Diet to Reduce Triglyceride Levels in Adult Patients with Severe Hypertriglyceridemia (= 500 mg/dL) -- --

DUBLIN, Ireland and BRIDGEWATER, N.J., June 01, 2023 -- Amarin Corporation plc today announced that Aaron Berg, Amarin’s Interim President and Chief Executive Officer and Tom Reilly,... | June 1, 2023

Clearbridge Investments LLC lowered its stake in shares of Amarin Co. plc (NASDAQ:AMRN – Get Rating) by 4.2% during the fourth quarter, Holdings Channel reports. The fund owned 535,234 shares of the biopharmaceutical company’s stock after selling 23,480 shares during the period. Clearbridge Investments LLC’s holdings in Amarin were worth $648,000 as of its most […]